Drug used to treat cocaine addiction could pave the way for new treatment for advanced colon cancer

Multiomic characterization of cancer-selective effects of VXN on cellular function. credit: natural cancer (2024). DOI: 10.1038/s43018-024-00727-y New cutting-edge research from the University of Ottawa (uOttawa) shows that vanoxerin, a drug originally developed to treat cocaine addiction, improves the ability of advanced colorectal cancer stem cells by essentially rewiring key gene networks. It has been found […]

Organoid drug testing predicts treatment response for colorectal cancer

A new study has proven that organoid drug tests are highly accurate in predicting effective treatments and uncovered new treatment options. A world-first study led by scientists at the Walter and Eliza Hall Medical Institute (WEHI) proves that an organoid drug test can predict response to treatment in patients with advanced colorectal cancer with 90% […]

Appendicitis Disease Market: Regional Coverage, Drug Insights, Epidemiological Studies, Clinical Trial Evaluation, and Price Reimbursement

London, October 12, 2023 /PRNewswire/ — appendicitis disease It is a common disease caused by an inflamed appendix. According to NIH research, approximately 5 to 9 out of 100 people will develop the disorder at some point. Due to the high disease burden, effective diagnostic and therapeutic methods are urgently needed. Landscape of illness_insight_logo Appendicitis […]

This woman’s colon cancer disappeared after taking a new drug for six months.

The 42-year-old woman had no evidence of cancer after receiving dostarimab, a drug still in early trials to treat a rare form of colorectal cancer. advertisement Carrie Downey, a single mother with a 17-year-old son, was diagnosed with colon cancer a year ago, but after just six months of treatment with a new anti-cancer drug, […]

New drug combination shows efficacy against early colorectal cancer

Pathologist Erica Hisson (left) and oncologist Pashtun Kashi (right) are two of the scientists involved in a new study demonstrating the effectiveness of a new immunotherapy for colorectal cancer. Weill Cornell Medicine When given before surgery, a combination immunotherapy developed by biotechnology company Agenus destroyed more than 80% of the tumor before it could be […]